NLRP3 and acute lymphoblastic leukemia: Paugh et al. (2016) reported that decreased methylation of the Caspase-1 promoter results in increased transcription and activation of NLRP3 and Caspase1, which cleaves the glucocorticoid receptors used in the treatment of ALL, what suggests their association with relapse episodes10, 39.